More Capacity and Technology Translate to More Options

Publication
Article
BioPharm InternationalBioPharm International-02-15-2020
Volume 2020 eBook
Issue 1
Pages: 6

Technology and capacity investments create opportunities in the cell and gene therapy arena for CDMOs and biopharma alike.

Emerging therapies are testing the capabilities of biologic drug manufacturing companies, as well as contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs). Manufacturers are employing process optimization and scalable advanced technologies to produce more product in less floor space. In addition, CDMOs have stepped up investments in cell and gene therapy development and manufacturing While this consolidation means there are fewer competitors in the market, industry experts see benefits including standardization of methods, simplified vendor management, and use of advanced technologies.

Read this article in BioPharm International’s February 2020 Partnerships for Outsourcing eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources, February 2020
February 2020
Page: 6

Citation

When referring to this article, please cite it as R.Peters, “More Capacity and Technology Translate to More Options," BioPharm International Outsourcing ResourceseBook (February 2020).

 

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.